Humana INC Form 4 insider transactions

John-Paul W. Felter, SVP, Chief Accounting Officer & Controller of Humana Inc., reports acquisition and disposal of Humana common stock and restricted stock units.

Celeste Mellet, CFO of Humana Inc., reports acquiring 6,385 shares of Humana common stock on February 24, 2025.

David Dintenfass, President of Enterprise Growth at Humana Inc., reports acquisition and disposal of Humana common stock and stock options.

Humana's Chief Strategy & Corporate Development Officer, Vishal Agrawal, reports acquisition and disposition of Humana common stock and stock options.

George Renaudin II, President of Insurance at Humana Inc., reports transactions involving Humana common stock and derivative securities.

Joseph C. Ventura, Chief Legal Officer of Humana Inc., reports transactions involving Humana common stock and derivative securities.

Celeste Mellet, Humana's Chief Financial Officer, reported the acquisition of 23,291 shares of Humana common stock on February 13, 2025.

Chief Information Officer of Humana Inc., Japan Mehta, reports the acquisition of 5,046 restricted stock units on February 13, 2025.

Humana's President and CEO, James A. Rechtin, reports the vesting of restricted stock units and associated tax liability payment.

Director Marcy S. Klevorn reports acquisition of Humana stock units through director's fees and dividend reinvestment.

Director Wayne A.I. Frederick reports acquisition of Humana stock units through director's fees and dividend reinvestment.

Director Frank A. D'Amelio of Humana Inc. reports the acquisition of restricted stock units and the transfer of common stock into a grantor retained annuity trust.

Michelle A. O'Hara, Chief Human Resources Officer at Humana Inc., acquired 7,061 restricted stock units on January 1, 2025.

Humana director Karen Katz reported the acquisition of restricted stock units through deferred compensation and dividend reinvestment.

Director Kurt J. Hilzinger of Humana Inc. reports the acquisition of restricted stock units through deferred compensation and dividend reinvestment.

Humana's Chief Financial Officer, Susan Diamond, reported transactions involving company stock, including the disposition of shares and the holding of various derivative securities.

Humana director Gordon Smith acquired 783 restricted stock units as part of his annual director's fee, and holds 765 other restricted stock units.

Director Raquel C. Bono reports acquisition of Humana stock units related to director fees and dividend reinvestment.

Humana's Chief Administrative Officer, Timothy S. Huval, reported the sale of 3,703 shares and a charitable donation of 1,070 shares of Humana common stock on December 31, 2024, along with details of various stock options and restricted stock units.

Humana director John W. Garratt acquired 783 restricted stock units and received 2 stock units as a dividend reinvestment.

Humana director David T. Feinberg reported the acquisition of restricted stock units through deferred compensation and dividend reinvestment.

Director Brad D. Smith reports acquisition and disposal of Humana Inc. stock and stock units.

Humana director Jorge S. Mesquita acquired 783 restricted stock units on January 2, 2025, representing a contingent right to receive common stock.

Humana's Chief Strategy and Corporate Development Officer, Vishal Agrawal, reports the vesting and tax withholding of restricted stock units and the acquisition of shares through option exercises.

Humana's President and CEO, James A. Rechtin, reported the disposal of 392 shares of common stock to cover tax liabilities related to vested restricted stock units.

Humana's Chief Information Officer, Samir Deshpande, reported the vesting of restricted stock units and the subsequent sale of shares to cover tax liabilities.

Humana's President of Insurance, George Renaudin II, reported multiple transactions involving company stock, including the vesting of restricted stock units and the sale of shares to cover tax liabilities.

Humana's SVP, Chief Accounting Officer & Controller, John-Paul W. Felter, reported the vesting and subsequent sale of shares to cover tax liabilities related to restricted stock units.

Humana executive Sanjay K. Shetty reports the vesting of restricted stock units and associated tax liability transactions.

Humana executive David Dintenfass disposed of 261 shares to cover tax liabilities from vested restricted stock units and holds 51,389 stock options.